Participation in the certificate of advanced studies (CAS) "Integrative and complementary medicine in hospitals and the community"
Medical Oncology
General Internal Medicine
Générale-Beaulieu Swiss Oncology Network
Chemin de Beau-Soleil 20
1206 Genève
Participation in the certificate of advanced studies (CAS) "Integrative and complementary medicine in hospitals and the community"
FMH title of specialist in internal medicine
FMH title of specialist in medical oncology
Geneva University of Medicine, federal diploma in medicine
Senior consultant in the medical oncology department of the University Hospitals of Geneva (inpatient, outpatient)
Outpatient medical oncology (Geneva University Hospitals), including one year in clinical research (research unit of the Dr Henri Dubois-Ferrière Dinu Lipatti Foundation)
General internal medicine (Hôpital de la Tour, then University Hospitals of Geneva) (in-hospital, emergency, intensive care)
Patient-reported experiences of cancer care related to the COVID-19 pandemic in Switzerland. S Colomer-Lahiguera, C Canella, S Giacomini, K Lê Van, C Pedrazzani, M Naegele, L Thouvenin, A O'Meara Stern, R Condorelli, T Corbière, C Witt, M Eicher, K Ribi. Support Care Cancer. 2023 Jun 22;31(7):410. doi: 10.1007/s00520-023-07871-8.
Differential impact of tamoxifen and aromatase inhibitors on thrombin generation : the prospective HEMOBREAST cohort. Blondon M, Bodmer A, Thouvenin L, Lecompte T, Righini M, Fontana P, Casini A.Blood Adv. 2022 May 10;6(9):2884-2892. doi: 10.1182/bloodadvances.2021006623
Ovarian cancer with high-level focal ERBB2 amplification responds to trastuzumab and pertuzumab. Thouvenin L, Charrier M, Clement S, Christinat Y, Tille JC, Frigeri M, Homicsko K, Michielin O, Bodmer A, Chappuis PO, McKee TA, Tsantoulis P.Gynecol Oncol Rep. 2021 May 19;37:100787. doi: 10.1016/j.gore.2021.100787. eCollection 2021 Aug
Immune checkpoint inhibitor-induced aseptic meningitis and encephalitis : a case-series and narrative review. Thouvenin L, Olivier T, Banna G, Addeo A, Friedlaender A. Ther Adv Drug Saf. 2021 Mar 29;12:20420986211004745. doi: 10.1177/20420986211004745. eCollection 2021
A new hope in the treatment of hepatocellular carcinoma. Thouvenin L, Friedlaender A.Rev Med Suisse. 2020 May 27;16(695):1074-1078
Durable response to palbociclib and letrozole in ovarian cancer with CDKN2A loss. Frisone D, Charrier M, Clement S, Christinat Y, Thouvenin L, Homicsko K, Michielin O, Bodmer A, Chappuis PO, McKee TA, Tsantoulis P.Cancer Biol Ther. 2020;21(3):197-202. doi: 10.1080/15384047.2019.1685291. Epub 2019 Nov 10
Monoclonal gammopathies: from MGUS to multiple myeloma. Thouvenin L, Lang N.Rev Med Suisse. 2019 May 15;15(651):1022-1026